Shude Cui
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
Papers in
-
- Breast Cancer Treatment Studies 20
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 2
- Oncology 19
- HER2/EGFR in Cancer Research 6
- Cancer Risks and Factors 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- Zhenzhen Liu (10 shared papers)Hengwei Zhang (6 shared papers)Dechuang Jiao (5 shared papers)Min Yan (10 shared papers)Huijie Fan (1 shared paper)Qingyuan Zhang (4 shared papers)Ying Cheng (3 shared papers)Tao Sun (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)European Journal of Cancer (3 papers)The Lancet Oncology (2 papers)Tumor Biology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Shude Cui
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 64
- Cancer Research 433
- Oncology 386
- Biomaterials 83
- Pulmonary and Respiratory Medicine 203
- Drug Discovery 1
Countries citing papers authored by Shude Cui
This map shows the geographic impact of Shude Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shude Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shude Cui more than expected).
Fields of papers citing papers by Shude Cui
This network shows the impact of papers produced by Shude Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shude Cui. The network helps show where Shude Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Shude Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 224 | |
| 2 | 2019 | 153 | |
| 3 | 2014 | 98 | |
| 4 | 2020 | 77 | |
| 5 | 2019 | 71 | |
| 6 | 2022 | 59 | |
| 7 | 2017 | 54 | |
| 8 | 2011 | 52 | |
| 9 | 2012 | 47 | |
| 10 | 2013 | 45 | |
| 11 | 2014 | 45 | |
| 12 | 2020 | 42 | |
| 13 | 2017 | 35 | |
| 14 | 2017 | 26 | |
| 15 | 2020 | 21 | |
| 16 | 2015 | 20 | |
| 17 | 2015 | 20 | |
| 18 | 2015 | 16 | |
| 19 | 2013 | 14 | |
| 20 | 2015 | 14 |
About Shude Cui
Shude Cui is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Risks and Factors (4 papers), MicroRNA in disease regulation (3 papers), Brain Metastases and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (433 citations), Oncology (386 citations), Biomaterials (83 citations), Pulmonary and Respiratory Medicine (203 citations) and Drug Discovery (1 citation). Shude Cui has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhenzhen Liu, Hengwei Zhang, Dechuang Jiao, Min Yan, Huijie Fan, Qingyuan Zhang, Ying Cheng, Tao Sun, Xuhui Guo and Cuizhi Geng. Their work appears in journals such as Frontiers in Oncology, European Journal of Cancer, The Lancet Oncology, Tumor Biology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.